High Efficiency of Antiviral CD4+ Killer T Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Hildemann, Steven K ^a,b   Eberlein, Jens ^c   Davenport, Bennett ^c,d,e   Nguyen, Tom T ^c,e   Victorino, Francisco ^c,d   Homann, Dirk ^c,d,e  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b Merck Research Laboratories MSD Global Clinical Trial Operations   (Germany)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL KILLING; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EXOCYTOSIS; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; BACTERIA; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; VIRUSES;

BACTERIA (MICROORGANISMS);

EID: 84875662589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060420     Document Type: Article

References (58)

1. Appay V, (2004) The physiological role of cytotoxic CD4(+) T-cells: the holy grail? Clin Exp Immunol 138: 10-13.
2. van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R, (2008) Cytotoxic human CD4(+) T cells. Curr Opin Immunol 20: 339-343.
3. Brown DM, (2010) Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy. Cell Immunol 262: 89-95.
4. Soghoian DZ, Streeck H, (2010) Cytolytic CD4(+) T cells in viral immunity. Expert Rev Vaccines 9: 1453-1463.
5. Martorelli D, Muraro E, Merlo A, Turrini R, Rosato A, et al. (2010) Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer. Int Rev Immunol 29: 371-402.
6. Marshall NB, Swain SL, (2011) Cytotoxic CD4 T cells in antiviral immunity. J Biomed Biotechnol 2011: 954602.
7. Barchet W, Oehen S, Klenerman P, Wodarz D, Bocharov G, et al. (2000) Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo. Eur J Immunol 30: 1356-1363.
8. Jellison ER, Kim SK, Welsh RM, (2005) Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol 174: 614-618.
9. Matter MS, Hilmenyuk T, Claus C, Marone R, Schurch C, et al. (2011) Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells. PLoS ONE 6: e24772.
10. Brien JD, Uhrlaub JL, Nikolich-Zugich J, (2008) West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 181: 8568-8575.
11. Fang M, Siciliano NA, Hersperger AR, Roscoe F, Hu A, et al. (2012) Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection. Proc Natl Acad Sci U S A 109: 9983-9988.
12. Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, et al. (2010) CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol 185: 5405-5416.
13. Stuller KA, Flano E, (2009) CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection. J Virol 83: 4700-4703.
14. Stuller KA, Cush SS, Flano E, (2010) Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations. J Immunol 184: 3850-3856.
15. Whitmire JK, (2011) Induction and function of virus-specific CD4+ T cell responses. Virology 411: 216-228.
16. Homann D, Teyton L, Oldstone MB, (2001) Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 7: 913-919.
17. Barber DL, Wherry EJ, Ahmed R, (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 171: 27-31.
18. Oxenius A, Bachmann MF, Ashton-Rickardt PG, Tonegawa S, Zinkernagel RM, et al. (1995) Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur J Immunol 25: 3402-3411.
19. Homann D, Lewicki H, Brooks D, Eberlein J, Mallet-Designe V, et al. (2007) Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II. Virology 363: 113-123.
20. Homann D, McGavern DB, Oldstone MB, (2004) Visualizing the viral burden: phenotypic and functional alterations of T cells and APCs during persistent infection. J Immunol 172: 6239-6250.
21. Aichele P, Brduscha-Riem K, Oehen S, Odermatt B, Zinkernagel RM, et al. (1997) Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6: 519-529.
22. Geginat G, Schenk S, Skoberne M, Goebel W, Hof H, (2001) A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J Immunol 166: 1877-1884.
23. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281: 65-78.
24. Wolint P, Betts MR, Koup RA, Oxenius A, (2004) Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med 199: 925-936.
25. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM, (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
26. Kaech SM, Hemby S, Kersh E, Ahmed R, (2002) Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
27. Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H, (1998) Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur J Immunol 28: 390-400.
28. Williams MA, Ravkov EV, Bevan MJ, (2008) Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory. Immunity 28: 533-545.
29. Russell JH, Ley TJ, (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20: 323-370.
30. Hudrisier D, Mazarguil H, Laval F, Oldstone MB, Gairin JE, (1996) Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. Implications for peptide selection and presentation. J Biol Chem 271: 17829-17836.
31. van der Most RG, Murali-Krishna K, Whitton JL, Oseroff C, Alexander J, et al. (1998) Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240: 158-167.
32. Hudrisier D, Riond J, Gairin JE, (2001) Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus. J Virol 75: 2468-2471.
33. Byers AM, Kemball CC, Moser JM, Lukacher AE, (2003) Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol 171: 17-21.
34. Yates A, Graw F, Barber DL, Ahmed R, Regoes RR, et al. (2007) Revisiting Estimates of CTL Killing Rates In Vivo. PLoS ONE 2: e1301.
35. Seder RA, Ahmed R, (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 4: 835-842.
36. Lenz DC, Kurz SK, Lemmens E, Schoenberger SP, Sprent J, et al. (2004) IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc Natl Acad Sci U S A 101: 9357-9362.
37. Homann D, Dummer W, Wolfe T, Rodrigo E, Theofilopoulos AN, et al. (2006) Lack of intrinsic ctla-4 expression has minimal effect on regulation of antiviral T-cell immunity. J Virol 80: 270-280.
38. Eberlein J, Davenport B, Nguyen TT, Victorino F, Sparwasser T, et al. (2012) Multiple Layers of CD80/86-Dependent Costimulatory Activity Regulate Primary, Memory, and Secondary Lymphocytic Choriomeningitis Virus-Specific T Cell Immunity. J Virol 86: 1955-1970.
39. Jellison ER, Guay HM, Szomolanyi-Tsuda E, Welsh RM, (2007) Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen. Eur J Immunol 37: 119-128.
40. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, et al. (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37.
41. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, et al. (1994) Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A 91: 10854-10858.
42. Balkow S, Kersten A, Tran TT, Stehle T, Grosse P, et al. (2001) Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol 75: 8781-8791.
43. Rode M, Balkow S, Sobek V, Brehm R, Martin P, et al. (2004) Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection. J Virol 78: 12395-12405.
44. Pardo J, Bosque A, Brehm R, Wallich R, Naval J, et al. (2004) Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis. J Cell Biol 167: 457-468.
45. Joeckel LT, Wallich R, Martin P, Sanchez-Martinez D, Weber FC, et al. (2011) Mouse granzyme K has pro-inflammatory potential. Cell Death Differ 18: 1112-1119.
46. Jenkins MR, Trapani JA, Doherty PC, Turner SJ, (2008) Granzyme K expressing cytotoxic T lymphocytes protects against influenza virus in granzyme AB-/- mice. Viral Immunol 21: 341-346.
47. Regner M, Pavlinovic L, Koskinen A, Young N, Trapani JA, et al. (2009) Cutting edge: rapid and efficient in vivo cytotoxicity by cytotoxic T cells is independent of granzymes A and B. J Immunol. 183: 37-40.
48. Marshall HD, Chandele A, Jung YW, Meng H, Poholek AC, et al. (2011) Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection. Immunity 35: 633-646.
49. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234.
50. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, et al. (2008) Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29: 720-733.
51. Kaufmann SH, Hug E, Vath U, De Libero G, (1987) Specific lysis of Listeria monocytogenes-infected macrophages by class II-restricted L3T4+ T cells. Eur J Immunol 17: 237-246.
52. Serody JS, Poston RM, Weinstock D, Kurlander RJ, Frelinger JA, (1996) CD4+ cytolytic effectors are inefficient in the clearance of Listeria monocytogenes. Immunology 88: 544-550.
53. Woodworth JS, Wu Y, Behar SM, (2008) Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. J Immunol 181: 8595-8603.
54. Korns Johnson D, Homann D, (2012) Accelerated and improved quantification of lymphocytic choriomeningitis virus (LCMV) titers by flow cytometry. PLoS ONE 7: e37337.
55. Homann D, Tishon A, Berger DP, Weigle WO, von Herrath MG, et al. (1998) Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J Virol 72: 9208-9216.
56. Shen H, Slifka MK, Matloubian M, Jensen ER, Ahmed R, et al. (1995) Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A 92: 3987-3991.
57. Eberlein J, Nguyen TT, Victorino F, Golden-Mason L, Rosen HR, et al. (2010) Comprehensive assessment of chemokine expression profiles by flow cytometry. J Clin Invest 120: 907-923.
58. Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, et al. (2004) The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285: 25-40.